Press Release
BIOGEN AND INNOCARE ANNOUNCE DOSING OF FIRST PATIENT IN PHASE 2 CLINICAL TRIAL OF ORELABRUTINIB FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN CHINA
14 Oct, 2021
90
3612
Mantle Cell Lymphoma Clinical Trail Sites in U.S.
01 Oct, 2021
113
3571
InnoCare and Keymed Jointly Announce Approval of Clinical Trial of CD20xCD3 Bispecific Antibody CM355
16 Sep, 2021
135
3545
InnoCare Announces Clearance by U.S. FDA of Clinical Trial of pan-TRK Inhibitor ICP-723
31 Aug, 2021
116
3522
InnoCare Releases 2021 Half Year Results and Business Highlights
29 Aug, 2021
179
3514
Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China
17 Aug, 2021
166
3504
InnoCare Announces First Subject Dosed in Clinical Trial of ICP-332
16 Aug, 2021
108
3500
InnoCare Announces Approval of Phase II Clinical Trial Using Orelabrutinib for the Treatment of ITP in China
11 Aug, 2021
89
3498